作者
Isobel M Blake, Margarita Pons-Salort, Natalie A Molodecky, Ousmane M Diop, Paul Chenoweth, Ananda S Bandyopadhyay, Michel Zaffran, Roland W Sutter, Nicholas C Grassly
发表日期
2018/8/30
期刊
New England Journal of Medicine
卷号
379
期号
9
页码范围
834-845
出版商
Massachusetts Medical Society
简介
Background
Mass campaigns with oral poliovirus vaccine (OPV) have brought the world close to the eradication of wild poliovirus. However, to complete eradication, OPV must itself be withdrawn to prevent outbreaks of vaccine-derived poliovirus (VDPV). Synchronized global withdrawal of OPV began with serotype 2 OPV (OPV2) in April 2016, which presented the first test of the feasibility of eradicating all polioviruses.
Methods
We analyzed global surveillance data on the detection of serotype 2 Sabin vaccine (Sabin-2) poliovirus and serotype 2 vaccine–derived poliovirus (VDPV2, defined as vaccine strains that are at least 0.6% divergent from Sabin-2 poliovirus in the viral protein 1 genomic region) in stool samples from 495,035 children with acute flaccid paralysis in 118 countries and in 8528 sewage samples from four countries at high risk for transmission; the samples were collected from January 1, 2013 …
引用总数
2018201920202021202220232024551314986
学术搜索中的文章
IM Blake, M Pons-Salort, NA Molodecky, OM Diop… - New England Journal of Medicine, 2018